Search - tctmd.com

Displaying 201 - 220 of 1043

Sort: Relevancy | Date

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

L.A. McKeown

May 31, 2023

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

News Conference News EuroPCR 2023

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

Caitlin E. Cox

May 24, 2023

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

Presentation EuroPCR 2023

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

Presenter: Shigeru Saito

May 18, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Conference News EuroPCR 2023

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

Shelley Wood

May 16, 2023

News Daily News

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Michael O'Riordan

May 09, 2023

News Daily News

Cath Lab Garbage: ‘What Are We Going to Do About It?’

Michael O'Riordan

May 08, 2023

News Daily News

Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Shelley Wood

April 25, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

News Conference News ACC 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

L.A. McKeown

March 09, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

Presentation ACC 2023

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Presenter: Annapoorna S. Kini

March 06, 2023

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

News Conference News ACC 2023

On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET

Caitlin E. Cox

March 04, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

Advertisement

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Cath Lab Garbage: ‘What Are We Going to Do About It?’

Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

March 2023 News Roundup

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content